Editorial Comment

Affiliations

Editorial

Alex Sankin. J Urol. 2022 Oct.

. 2022 Oct;208(4):828-829.

doi: 10.1097/JU.0000000000002778.01. Epub 2022 Jul 13.

¹ Department of Urology, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York.

No abstract available

Comment on

Phase 1/2 Trial Results of a Large Surface Area Microparticle Docetaxel for the Treatment of High-Risk Nonmuscle-Invasive Bladder Cancer.
Kates M, Mansour AM, Lamm DL, Shore N, Maulhardt H, Wendt A, Verco J, Marin A, Dewnani K, Verco S, diZerega GS. Kates M, et al. J Urol. 2022 Oct;208(4):821-829. doi: 10.1097/JU.0000000000002778. Epub 2022 May 16. J Urol. 2022. PMID: 35574612 Clinical Trial.